Clinical Trials Directory

Trials / Unknown

UnknownNCT03618719

Impact of Intermittent Hypoxia on the Function of the Phagocytes

Impact of Intermittent Hypoxia on Phagocytosis and Sepsis Outcomes: the Potential Role of Statin (Part III: Human Study in 2018-2019)

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Taipei Veterans General Hospital, Taiwan · Other Government
Sex
All
Age
20 Years
Healthy volunteers
Accepted

Summary

Patients with treatment-naive obstructive sleep apnea (OSA) who need continuous positive airway pressure (CPAP) therapy on clinical basis are included as well as healthy controls without OSA. 15 cc peripheral venous blood is drawn on the date of diagnosis of OSA and 3-6 months after CPAP therapy. Granulocytes are harvested and tested for its function, such as phagocytosis, reactive oxygen species (ROS) production and bacteria-killing ability.

Detailed description

Patients with treatment-naive obstructive sleep apnea (OSA) who need continuous positive airway pressure (CPAP) therapy on clinical basis are included. Healthy controls without OSA are enrolled, too. 15 cc peripheral venous blood is drawn on the date of diagnosis of OSA and 3-6 months after CPAP therapy (not given to controls). Granulocytes are harvested and tested for its function, such as phagocytosis, reactive oxygen species (ROS) production and bacteria-killing ability.

Conditions

Timeline

Start date
2019-03-05
Primary completion
2019-07-03
Completion
2019-07-03
First posted
2018-08-07
Last updated
2019-03-12

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT03618719. Inclusion in this directory is not an endorsement.